Company updateMoneycontrol
Buy GlaxoSmithKline Pharmaceuticals; target of Rs 2900: ICICI Securities
Positive+1
GreyOak summary
ICICI Securities upgraded GlaxoSmithKline Pharmaceuticals to BUY with a target price of Rs 2,900. The broker raised FY27 and FY28 EPS estimates by 1% citing better margins. The stock trades at 32.5x FY28E earnings.
What it affects
- GlaxoSmithKline PharmaceuticalsGLAXOPositive +1
Rolling sentiment Neutral +1
Source
Read the original at MoneycontrolMore GlaxoSmithKline Pharmaceuticals news
No other recent stories about GlaxoSmithKline Pharmaceuticals.
All GlaxoSmithKline Pharmaceuticals news →